๐Ÿ”Ž Trials Near Me

Home โ€บ Skin Cancer

Skin Cancer clinical trials recruiting in the U.S.

44 studies for Skin Cancer are recruiting participants at sites across the United States.

Try ABCDE on a mole to check for signs of skin cancer: Asymmetry, Border, Color, Diameter, Elevation. Learn more on advanced detection and treatments.

Cities with the most studies

By state

Recently updated studies

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

RecruitingObservational studyHealthy volunteers welcome
4 Weeks โ€“ 99 Years ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00040352

Mobile Sun Health Intervention EnabLing Daily Protection

RecruitingHealthy volunteers welcome
Ages 18 to 29 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT07830394

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 16, 2026 ยท NCT06585410

Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 11, 2026 ยท NCT07062003

Cryoablation+Ipilimumab+Nivolumab in Melanoma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Aug 27, 2026 ยท NCT05779423

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Recruiting
Ages 18 and older ยท All sexes ยท Updated Aug 19, 2026 ยท NCT06298734

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 12, 2026 ยท NCT05859074

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

RecruitingPhase 4
Ages 18 and older ยท All sexes ยท Updated Aug 11, 2026 ยท NCT07426484

Rural Adult and Youth Sun Protection Study

RecruitingHealthy volunteers welcome
Ages 3 to 7 ยท All sexes ยท Updated Aug 10, 2026 ยท NCT06439979

Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Aug 6, 2026 ยท NCT06675643

The Florida ASCENT Study

Recruiting
Ages 18 to 100 ยท All sexes ยท Updated Jul 23, 2026 ยท NCT07042243

DNA Repair Activity in the Skin of Day and Night Shift Workers

RecruitingHealthy volunteers welcome
Ages 18 to 40 ยท All sexes ยท Updated Jul 17, 2026 ยท NCT04122456

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Jul 16, 2026 ยท NCT06060613

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Recruiting
Ages 18 and older ยท All sexes ยท Updated Jul 15, 2026 ยท NCT06615635

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Jun 29, 2026 ยท NCT07327489

Integrated Cancer Repository for Cancer Research

RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 ยท All sexes ยท Updated Jun 29, 2026 ยท NCT02012699

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

RecruitingEarly phase 1
Ages 18 and older ยท All sexes ยท Updated Jun 5, 2026 ยท NCT07286318

Mechanisms for Laser-Induced Rejuvenation

Recruiting
Ages 18 and older ยท All sexes ยท Updated May 22, 2026 ยท NCT06489301

Brodalumab in the Treatment of Immune-Related Adverse Events

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated May 13, 2026 ยท NCT06673329

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 ยท All sexes ยท Updated May 8, 2026 ยท NCT05655494

Raman Spectroscopy and Skin Cancer

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated May 7, 2026 ยท NCT06384924

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.